Molecular and biologic basis of upper gastrointestinal malignancy--esophageal carcinoma.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Surgical Oncology Clinics of North America

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1055-3207(02)00003-0PMID 12424849
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in Brief Microsatellite Instability Occurs Frequently and in Both Diploid and Aneuploid Cell Populations of Barrett ' s-associated Esophageal Adenocarcinomas '

  2006cited by this paper
• Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor α

  2005cited by this paper
• The Retinoblastoma Protein and Cell Cycle Control Review

  2004cited by this paper
• Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers.

  2001cited by this paper
• Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.

  2001cited by this paper
• Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

  2001cited by this paper
• TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

  2001cited by this paper
• Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population

  2001cited by this paper
• Genetic differences between adenocarcinomas arising in Barrett's esophagus and gastric mucosa.

  2001cited by this paper
• Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.

  2000cited by this paper
• Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma.

  2000cited by this paper
• Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression.

  2000cited by this paper
• Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.

  2000cited by this paper
• Fas ligand expression in esophageal carcinomas and their lymph node metastases

  2000cited by this paper
• Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus.

  2000cited by this paper
• Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma

  2000cited by this paper
• Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

  2000cited by this paper
• Molecular biology of esophageal squamous cell carcinoma.

  2000cited by this paper
• HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma.

  2000cited by this paper
• Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus.

  2000cited by this paper
• Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.

  2000cited by this paper
• Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

  1999cited by this paper
• Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities

  1999cited by this paper
• Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey.

  1999cited by this paper
• Significance of Fas and Retinoblastoma Protein Expression During the Progression of Barrett’s Metaplasia to Adenocarcinoma

  1999cited by this paper
• Evolution of neoplastic cell lineages in Barrett oesophagus

  1999cited by this paper
• Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.

  1999cited by this paper
• Expression of cyclin E in dysplasia, carcinoma, and nonmalignant lesions of barrett esophagus

  1999cited by this paper
• Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.

  1999cited by this paper
• Cyclooxygenase-2 expression in human esophageal carcinoma.

  1999cited by this paper
• Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma

  1999cited by this paper
• Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.

  1999cited by this paper
• Control of the cell cycle and apoptosis.

  1999cited by this paper
• Control of the cell cycle and apoptosis.

  1999cited by this paper
• Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations

  1999cited by this paper
• C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions.

  1998cited by this paper
• Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.

  1998cited by this paper
• Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells*

  1998cited by this paper
• Ceramide Regulates the Transcription of Cyclooxygenase-2

  1998cited by this paper
• RAS pathways to cell cycle control and cell transformation.

  1998cited by this paper
• The complexity of p53 modulation: emerging patterns from divergent signals.

  1998cited by this paper
• Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

  1998cited by this paper
• p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis.

  1998cited by this paper
• Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis

  1998cited by this paper
• Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus.

  1998cited by this paper
• Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.

  1998cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions

  1997cited by this paper
• p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history.

  1997cited by this paper
• p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas.

  1997cited by this paper
• Expression of p53, PCNA, and C-erbB-2 in Barrett's Metaplasia and Adenocarcinoma

  1997cited by this paper
• Cancer statistics, 1997

  1997cited by this paper
• High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.

  1997cited by this paper
• Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.

  1997cited by this paper
• The host-tumor immune conflict: from immunosuppression to resistance and destruction.

  1997cited by this paper
• Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.

  1997cited by this paper
• Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers

  1997cited by this paper
• The role of FasL-induced apoptosis in immune privilege.

  1997cited by this paper
• Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.

  1997cited by this paper
• Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.

  1997cited by this paper
• Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma.

  1997cited by this paper
• Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patients

  1997cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms.

  1996cited by this paper
• Increased expression of the cyclin D1 gene in Barrett's esophagus.

  1996cited by this paper
• Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

  1996cited by this paper
• Fas ligand and immune evasion

  1996cited by this paper
• 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus.

  1996cited by this paper
• Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.

  1996cited by this paper
• Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review

  1996cited by this paper
• K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.

  1996cited by this paper
• Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma.

  1996cited by this paper
• Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas

  1996cited by this paper
• Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables

  1995cited by this paper
• Transcriptional Regulation of Human Prostaglandin-endoperoxide Synthase-2 Gene by Lipopolysaccharide and Phorbol Ester in Vascular Endothelial Cells

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers.

  1995cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma.

  1994cited by this paper
• TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus.

  1994cited by this paper
• Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.

  1994cited by this paper
• The MTS1 gene is frequently mutated in primary human esophageal tumors.

  1994cited by this paper
• p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia.

  1994cited by this paper
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

  1994cited by this paper
• Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification

  1994cited by this paper
• Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy

  1994cited by this paper
• Expression of APO‐1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium

  1994cited by this paper
• NIH Consensus Conference on laparoscopic cholecystectomy: are reforms necessary.

  1993cited by this paper
• Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.

  1993cited by this paper
• Continuing climb in rates of esophageal adenocarcinoma: an update.

  1993cited by this paper
• Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.

  1993cited by this paper
• Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.

  1993cited by this paper
• Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.

  1993cited by this paper
• Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.

  1993cited by this paper
• Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

  1993cited by this paper
• Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines.

  1993cited by this paper
• p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study.

  1993cited by this paper
• Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma.

  1992cited by this paper

• Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications.

  2024cites this paper
• Characteristics of miRNA interaction with mRNA in 5'UTR, CDS and 3'UTR of candidate genes of esophageal and stomach cancer

  2018cites this paper
• Activation of NADPH oxidases leads to DNA damage in esophageal cells

  2017cites this paper
• Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats.

  2016cites this paper
• In vivo multiplexed molecular imaging of esophageal cancer via spectral endoscopy of topically applied SERS nanoparticles.

  2015cites this paper
• Pathogenetic mechanisms in gastric cancer.

  2014cites this paper
• Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis

  2014cites this paper
• Comprehensive spectral endoscopy of topically applied SERS nanoparticles in the rat esophagus.

  2014cites this paper
• Chemoprevention of esophageal squamous cell carcinoma with berries.

  2013cites this paper
• Natural Products in Cancer Prevention and Therapy

  2013cites this paper
• Cellular stress response in Eca-109 cells inhibits apoptosis during early exposure to isorhamnetin.

  2012cites this paper
• Squamous cell cancer of the esophagus: the forgotten one.

  2011cites this paper
• Randomized Phase II Trial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus

  2011influential citation
• Mechanistic basis for the chemopreventive effects of black raspberries at a late stage of rat esophageal carcinogenesis

  2011cites this paper
• p73 protein regulates DNA damage repair

  2011cites this paper
• [Immunohistochemical expression of P53 and Ki-67 in diethylnitrosamine-induced carcinomas esophageal: experimental model].

  2010cites this paper
• Cytokines and Growth Factors Expressed by Human Cutaneous Melanoma

  2010cites this paper
• Expressão imunohistoquímica de P53 e Ki-67 na carcinogênese esofágica induzida pela dietilnitrosamina: modelo experimental

  2010cites this paper
• Berry ellagitannins may not be sufficient for prevention of tumors in the rodent esophagus.

  2010cites this paper
• Anthocyanins in Black Raspberries Prevent Esophageal Tumors in Rats

  2009cites this paper
• E Series of Prostaglandin Receptor 2-Mediated Activation of Extracellular Signal-Regulated Kinase/Activator Protein-1 Signaling Is Required for the Mitogenic Action of Prostaglandin E2 in Esophageal Squamous-Cell Carcinoma

  2008cites this paper
• Chemoprevention of esophageal squamous cell carcinoma.

  2007cites this paper
• Prevention and therapy of squamous cell carcinoma of the rodent esophagus using freeze-dried black raspberries

  2007cites this paper
• Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells.

  2007cites this paper
• Tumor-associated macrophages and CD3-ζ expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.

  2007cites this paper
• Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma.

  2007cites this paper
• MODELO EXPERIMENTAL DE CARCINOGÊNESE ESOFÁGICA EXPERIMENTAL MODEL OF ESOPHAGEAL CARCINOGENESIS

  2007cites this paper
• Modelo experimental de carcinogênese esofágica

  2007cites this paper
• Discovery of deregulation of zinc homeostasis and its associated genes in esophageal squamous cell carcinoma using cDNA microarray

  2007cites this paper
• Part 1 of a 3-Part Series on Genetic Testing: Diseases of the Esophagus And Stomach

  2006cites this paper
• Growth Factors and Oncogenes in Gastrointestinal Cancers

  2006cites this paper
• Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study

  2006cites this paper
• EXPRESSÃO IMUNOHISTOQUÍMICA D0 p53 E Ki-67 NA CARCINOGÊNESE ESOFÁGICA INDUZIDA PELA DIETILNITROSAMINA: MODELO EXPERIMENTAL EM CAMUNDONGOS

  2005cites this paper
• Expression of Macrophage Migration Inhibitory Factor in Esophageal Squamous Cell Carcinoma and Effects of Bile Acids and NSAIDs Running title: MIF in esophageal squamous cell carcinoma

  2004cites this paper
• Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.

  2004cites this paper
• Oesophageal Carcinoma : A Review 25 Oesophageal Carcinoma : A Review

  2004cites this paper